» Articles » PMID: 30559216

Glycosphingolipid Metabolism in Cell Fate Specification

Overview
Journal J Cell Sci
Specialty Cell Biology
Date 2018 Dec 19
PMID 30559216
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Glycosphingolipids (GSLs) are ubiquitous components of eukaryotic plasma membranes that consist of a ceramide backbone linked to a glycan moiety. Both the ceramide and the glycan parts of GSLs display structural variations that result in a remarkable repertoire of diverse compounds. This diversity of GSLs is exploited during embryogenesis, when different GSLs are produced at specific developmental stages and along several differentiation trajectories. Importantly, plasma membrane receptors interact with GSLs to modify their activities. Consequently, two otherwise identical cells can respond differently to the same stimulus owing to their different GSL composition. The metabolic reprograming of GSLs is in fact a necessary part of developmental programs, as its impairment results in developmental failure or tissue-specific defects. Moreover, single-cell variability is emerging as a fundamental player in development: GSL composition displays cell-to-cell variability in syngeneic cell populations owing to the regulatory gene expression circuits involved in microenvironment adaptation and in differentiation. Here, we discuss how GSLs are synthesized and classified and review the role of GSLs in the establishment and maintenance of cell identity. We further highlight the existence of the regulatory circuits that modify GSL pathways and speculate how GSL heterogeneity might contribute to developmental patterning.

Citing Articles

Miglustat ameliorates isoproterenol-induced cardiac fibrosis via targeting UGCG.

Liu J, Li W, Jiao R, Liu Z, Zhang T, Chai D Mol Med. 2025; 31(1):55.

PMID: 39934657 PMC: 11812238. DOI: 10.1186/s10020-025-01093-w.


Sphingolipid metabolites involved in the pathogenesis of atherosclerosis: perspectives on sphingolipids in atherosclerosis.

Zhao F, Shao M, Li M, Li T, Zheng Y, Sun W Cell Mol Biol Lett. 2025; 30(1):18.

PMID: 39920588 PMC: 11804087. DOI: 10.1186/s11658-024-00679-2.


Ganglioside GD2 Contributes to a Stem-Like Phenotype in Intrahepatic Cholangiocarcinoma.

Mannini A, Pastore M, Giachi A, Correnti M, Spinola Lasso E, Lottini T Liver Int. 2024; 45(1):e16208.

PMID: 39726234 PMC: 11684508. DOI: 10.1111/liv.16208.


Linking glycosphingolipid metabolism to disease-related changes in the plasma membrane proteome.

Monkhouse H, Deane J Biochem Soc Trans. 2024; 52(6):2477-2486.

PMID: 39641585 PMC: 11668283. DOI: 10.1042/BST20240315.


Unraveling the glycosphingolipid metabolism by leveraging transcriptome-weighted network analysis on neuroblastic tumors.

Ustjanzew A, Nedwed A, Sandhoff R, Faber J, Marini F, Paret C Cancer Metab. 2024; 12(1):29.

PMID: 39449099 PMC: 11515559. DOI: 10.1186/s40170-024-00358-y.